|Bid||0.0000 x 1800|
|Ask||0.0000 x 1800|
|Day's range||3.7900 - 4.1200|
|52-week range||3.1700 - 11.6100|
|Beta (5Y monthly)||1.21|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||14 Oct 1999|
|1y target est||N/A|
PHILADELPHIA, January 09, 2023--Rite Aid Corporation (NYSE: RAD) ("Rite Aid" or the "Company") announced today that its Board of Directors has appointed Elizabeth ("Busy") Burr, a member of the Company’s Board, as interim CEO, effective immediately. Burr’s appointment follows Heyward Donigan’s departure from the Company as President and CEO, and as a member of the Board. Rite Aid has initiated a search to identify a permanent CEO and has retained a leading executive search firm.
PHILADELPHIA, December 21, 2022--Rite Aid Corporation (NYSE: RAD) today reported operating results for its third fiscal quarter ended November 26, 2022.
PHILADELPHIA, December 15, 2022--Following FDA authorization and new CDC recommendations, select Rite Aid (NYSE: RAD) locations, including Bartell Drugs in the Pacific Northwest, are now offering the Pfizer-BioNTech bivalent COVID-19 Vaccine to children ages 3 and over. Rite Aid pharmacists are trained to administer vaccines 3 and older.